Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
4.990
-0.010 (-0.20%)
Jul 30, 2026, 1:35 PM CST
Market Cap3.78B -29.7%
Revenue (ttm)2.99B +20.9%
Net Income38.74M -63.5%
EPS0.05 -63.9%
Shares Out 755.68M
PE Ratio100.66
Forward PEn/a
Dividend0.10 (2.02%)
Ex-Dividend DateJun 1, 2026
Volume6,500,900
Open4.870
Previous Close5.000
Day's Range4.870 - 5.090
52-Week Range4.580 - 8.060
Beta0.40
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,713
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2025, SHE:002688's revenue was 2.88 billion, an increase of 21.41% compared to the previous year's 2.37 billion. Earnings were 27.56 million, a decrease of -72.50%.

Financial Statements